cytokine gene therapy (Stanford)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namecytokine gene therapy (Stanford)
Drug Alias Namesuppressor cytokines (Stanford)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1Multiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford University
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Multiple SclerosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A